264 related articles for article (PubMed ID: 19498198)
21. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Wiktor DM; Carroll JD
Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
[TBL] [Abstract][Full Text] [Related]
22. Assessment of morphology of patent foramen ovale with transesophageal echocardiography in symptomatic and asymptomatic patients.
Bayar N; Arslan Ş; Çağırcı G; Erkal Z; Üreyen ÇM; Çay S; Köklü E; Yüksel İÖ; Küçükseymen S
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1282-6. PubMed ID: 25906928
[TBL] [Abstract][Full Text] [Related]
23. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
[TBL] [Abstract][Full Text] [Related]
25. Risk of recurrent ischemic stroke in patients with patent foramen ovale: The role of D-dimer.
Park S; Kwon B; Oh JK; Song JK; Lee JS; Kwon SU
J Stroke Cerebrovasc Dis; 2023 Sep; 32(9):107246. PubMed ID: 37536016
[TBL] [Abstract][Full Text] [Related]
26. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL;
J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162
[TBL] [Abstract][Full Text] [Related]
27. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis.
Almekhlafi MA; Wilton SB; Rabi DM; Ghali WA; Lorenzetti DL; Hill MD
Neurology; 2009 Jul; 73(2):89-97. PubMed ID: 19439720
[TBL] [Abstract][Full Text] [Related]
28. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes and a high prevalence of abnormalities on comprehensive arterial and venous thrombophilia screening in TIA or ischaemic stroke patients with a patent foramen ovale, an inter-atrial septal aneurysm or both.
Lim ST; Murphy SJX; Smith DR; Williams J; Navarro SG; McCabe J; Moore DP; McHugh J; McCabe DJH
J Neurol Sci; 2017 Jun; 377():227-233. PubMed ID: 28477701
[TBL] [Abstract][Full Text] [Related]
30. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
Søndergaard L; Kasner SE; Rhodes JF; Andersen G; Iversen HK; Nielsen-Kudsk JE; Settergren M; Sjöstrand C; Roine RO; Hildick-Smith D; Spence JD; Thomassen L;
N Engl J Med; 2017 Sep; 377(11):1033-1042. PubMed ID: 28902580
[TBL] [Abstract][Full Text] [Related]
31. Morphometric Features of Patent Foramen Ovale as a Risk Factor of Cerebrovascular Accidents: A Systematic Review and Meta-Analysis.
Hołda MK; Koziej M
Cerebrovasc Dis; 2020; 49(1):1-9. PubMed ID: 32097931
[TBL] [Abstract][Full Text] [Related]
32. Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: A single-center experience.
He L; Cheng GS; Du YJ; Zhang YS
J Interv Cardiol; 2017 Aug; 30(4):362-367. PubMed ID: 28568903
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
[TBL] [Abstract][Full Text] [Related]
34. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M
Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819
[TBL] [Abstract][Full Text] [Related]
35. Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials.
Alushi B; Lauten A; Cassese S; Colleran R; Schüpke S; Rai H; Schunkert H; Meier B; Landmesser U; Kastrati A
Clin Res Cardiol; 2018 Sep; 107(9):788-798. PubMed ID: 29644412
[TBL] [Abstract][Full Text] [Related]
36. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D
Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198
[TBL] [Abstract][Full Text] [Related]
37. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Windecker S; Wahl A; Nedeltchev K; Arnold M; Schwerzmann M; Seiler C; Mattle HP; Meier B
J Am Coll Cardiol; 2004 Aug; 44(4):750-8. PubMed ID: 15312853
[TBL] [Abstract][Full Text] [Related]
38. Recurrent stroke and patent foramen ovale: a systematic review and meta-analysis.
Katsanos AH; Spence JD; Bogiatzi C; Parissis J; Giannopoulos S; Frogoudaki A; Safouris A; Voumvourakis K; Tsivgoulis G
Stroke; 2014 Nov; 45(11):3352-9. PubMed ID: 25293664
[TBL] [Abstract][Full Text] [Related]
39. Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events.
Mono ML; Geister L; Galimanis A; Jung S; Praz F; Arnold M; Fischer U; Wolff S; Findling O; Windecker S; Wahl A; Meier B; Mattle HP; Nedeltchev K
Stroke; 2011 Oct; 42(10):2891-5. PubMed ID: 21817145
[TBL] [Abstract][Full Text] [Related]
40. Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
Araszkiewicz A; Sławek S; Trojnarska O; Lesiak M; Grygier M
Catheter Cardiovasc Interv; 2018 Jul; 92(1):159-164. PubMed ID: 29068141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
